Ibandronate sodium

Ibandronate sodium is a bisphosphonate medication mainly used to treat and prevent osteoporosis in postmenopausal women. It helps reduce the risk of vertebral fractures by increasing bone mineral density (BMD) and slowing bone loss. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bondronat, Boniva and Ibandronate sodium anhydrous. Its PubChem CID is 23670359.

CAS No 138844-81-2
Molecular Formula C9H22NNaO7P2
Molecular Weight 341.21 g/mol
Synonyms sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate

Frequently Asked Questions